|
End-of-day quote
Buenos Aires S.E.
2026-08-19
|
5-day change | 1st Jan Change | ||
| 155.00 ARS | -1.90% |
|
-4.32% | -35.55% |
| Market Cap | 6.73B 4.5M 3.85M 3.58M 3.3M 6.2M 430M 6.31M 42.39M 16.61M 216M 16.88M 16.51M 710M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.47B 4.99M 4.27M 3.97M 3.67M 6.88M 478M 7M 47.04M 18.44M 240M 18.73M 18.32M 788M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.90% | ||
| 1 week | -4.32% | ||
| Current month | -2.82% | ||
| 1 month | -2.21% | ||
| 3 months | -4.91% | ||
| 6 months | -28.57% | ||
| Current year | -35.55% |
| 1 week | 153.5 |  | 162.5 |
| 1 month | 150 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 23 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 2010-07-29 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 2010-07-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.90% | -4.32% | -19.27% | +520.00% | 4.51M | |
| +3.68% | +1.77% | -49.66% | -57.77% | 30.56B | |
| +3.64% | +7.79% | +38.42% | +110.84% | 11.81B | |
| -2.19% | 0.00% | -17.85% | +5.74% | 3.95B | |
| +0.15% | -2.79% | -1.64% | +21.28% | 3.2B | |
| -2.52% | -4.09% | +47.53% | +37.20% | 2.18B | |
| +0.86% | -0.14% | +12.40% | +11.90% | 1.94B | |
| +2.28% | +3.99% | +13.41% | +133.93% | 1.41B | |
| -2.28% | +1.60% | -19.96% | +4.19% | 1.27B | |
| -1.91% | +1.06% | -11.76% | -42.95% | 1.03B | |
| Average | -0.26% | -0.92% | -0.84% | +74.44% | 5.74B | |
| Weighted average by Cap. | +1.20% | -0.45% | -17.97% | -1.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.53M 4.73M 4.4M 4.06M 7.63M 529M 7.76M 52.13M 20.43M 266M 20.75M 20.3M 874M | 6.4B 4.28M 3.66M 3.41M 3.14M 5.9M 410M 6.01M 40.34M 15.81M 206M 16.06M 15.71M 676M |
| Net income | -1.42B -947K -811K -754K -696K -1.31M -90.65M -1.33M -8.93M -3.5M -45.49M -3.55M -3.48M -150M | -4.6B -3.07M -2.63M -2.45M -2.26M -4.24M -294M -4.31M -28.97M -11.35M -148M -11.53M -11.28M -485M |
| Net Debt | 863M 577K 494K 459K 424K 796K 55.21M 810K 5.44M 2.13M 27.7M 2.16M 2.12M 91.14M | 738M 493K 422K 392K 362K 680K 47.18M 692K 4.65M 1.82M 23.68M 1.85M 1.81M 77.89M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-19 | ARS 155.00 | -1.90% | 6,369 |
| 26-08-18 | ARS 158.00 | +1.28% | 15,265 |
| 26-08-14 | ARS 156.00 | -2.50% | 2,457 |
| 26-08-13 | ARS 160.00 | +1.59% | 5,690 |
| 26-08-12 | ARS 157.50 | -2.78% | 2,404 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
